Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7487 p116-117
2 February 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• Clarke Inquiry (2)
• New professional body
• The Society (2)
• Community pharmacy (2)
• Pharmacy practice
• Technicians
• The industry
• WCPPE
• Drug addiction
• Research


Letters to the Editor

New professional body

Scotland must manage its own affairs

From Mr I. M. Mullen, MRPharmS

I was fascinated by Clare Bellingham’s excellent investigation of the rumours of Scotland’s desire for independence (PJ, 19 January 2008, p43).

People in England, perhaps understandably, have taken some time to appreciate the change that has taken place at all levels in Scotland as a result of the devolutionary process. In the early days of the Scottish Parliament, many UK-wide organisations with head offices in the south-east appeared to regard devolution as something of a little local difficulty that would have few implications for the manner in which they intended to continue to go about their business.

With a bit of pushing some, such as the Royal Pharmaceutical Society, reviewed their ways of working, changed some of the names and transferred a little more power to the natives. I am afraid that approach is no longer acceptable.

Scotland has a separate government and a separate NHS Act. Increasingly, the NHS in Scotland is developing differently from that in England or Wales. In principle, we still have a UK-wide health service, but all of the key decisions relating to the organisation, management, finance and delivery of the NHS in Scotland are now taken in Scotland.

Similarly, the Scottish pharmacy contract is markedly different from that in England, and the pace and range of development within community pharmacy in Scotland mean that the divergence apparent in the two NHS systems is clearly replicated within pharmacy.

Obviously, a future professional body must represent all pharmacists in Scotland, not only those involved in community pharmacy, but pharmacists working within the hospital service are also governed by the differing approach and ethos adopted by NHS Scotland. I suspect that industrial pharmacists based in Scotland might similarly feel the need to identify with the principles of devolution in making choices about their professional body.

What is required of a future professional body, I believe, is a clearer understanding of the differentiation between the application of management and the provision of governance. In my view, the current arrangement between the Royal Pharmaceutical Society and the Scottish Pharmacy Board allows the Society in Lambeth to manage the operation of the profession in Scotland, when what Scotland actually requires from Lambeth is effective governance as part of a UK-wide professional representative organisation.

If a future professional body is to have genuine appeal for pharmacists in Scotland, I firmly believe that it must allow the Scottish organisation to manage its own affairs and come together with some form of UK-wide body to provide an appropriate level of governance.

Ian Mullen
Auchterarder, Perthshire

Send your letter to The Editor

Previous Topic (Clarke Inquiry)
Next Topic (The Society)

Back to Top


©The Pharmaceutical Journal